The compounds [Mn2(bpm)3(NCS)4] (1), [Mn(bpm)(NCO)2] (2), and [Mn2(bpm)(N3)4] (3) (where bpm= 2,2‘-bipyrimidine) have been synthesized and characterized. Compound 1 crystallizes in the triclinic P1 space group, with a = 9.122(1) A, b = 9.229(1) A, c = 11.710(2) A, α = 74.89(1)°, β = 80.30(1)°, γ = 61.04(1)°, V = 831.7(2) A3, Z = 2, R(Fo) = 0.029, and wR(Fo2) = 0.078. Compound 2 crystallizes in the monoclinic C2/c space group, with a = 7.309(1) A, b = 14.498(2) A, c = 10.740(4) A, β = 99.93(4)°, V = 1121.0(5) A3, Z = 4, R = 0.025, and wR(Fo2) = 0.060. In the case of compound 3, the crystal parameters of the monoclinic C2/m space group are a = 6.206(2) A, b = 15.084(2) A, c = 8.909(1) A, β = 95.75(2)°, V = 829.8(3) A3, Z = 4, R = 0.029, and wR(Fo2)= 0.069. The pseudohalide ions have a dramatic influence in the molecular structures of the three compounds. Compound 1 is dinuclear, with the manganese(II) ions bridged by bpm ligands and with terminal bpm and NCS groups; compound 2 is a linear chain of manganes...